Intellia Therapeutics Inc (NTLA)

Other Income/Expenses (Net)

$6.13M

Quarterly · Period ending: · USD

NTLA logo

NTLA Other Income/Expenses (Net)

Latest reported$6.13M
NTLA Quarterly Other Income/Expenses (Net) ($11.00K → $6.13M)
High-resolution chart · PNG

NTLA other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Intellia Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
6,126,000
4,301,000
2,924,000
10,153,000
8,741,000
6,478,000
7,549,000
9,058,000
-7,932,000
6,567,000
7,731,000
8,883,000
8,653,000
8,832,000
-3,320,000
-7,699,000
-2,377,000
-2,626,000
-822,000
349,000
211,000
220,000
207,000
262,000
641,000
1,242,000
1,495,000
1,694,000
1,777,000
1,869,000
1,680,000
1,397,000
1,376,000
1,074,000
752,000
519,000
424,000
317,000
259,000
215,000
46,000
5,000
0
0
0
0
-3,027,500
11,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.